Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
INEXAS: Inhaled Interferon Beta-1a for Asthma Exacerbation Prevention
NCT02491684Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Jul 2015
- Primary completion
- Nov 2016
- Modality
- Cytokines & Interferons
- Countries
- 7
01
Overview
A Phase 2 trial of interferon beta-1a in asthma, sponsored by AstraZeneca. Started Jul 2015; status: completed.
02
Drugs
interferon beta-1a
03
Conditions
asthma
Beyond the preview
Go deeper on NCT02491684.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02491684.